Dual emission light‐emitting dendrimers composed of phosphorescent fac‐tris[2‐phenylpyridyl]iridium(III) [Ir(ppy)3] cores and thermally activated delayed fluorescence‐based (TADF‐based) dendrons have been prepared. The TADF‐based dendrons are designed to have green or blue emission. The dendrimers show solvatochromism, with the emission switching between phosphorescence and TADF depending on the medium in which the measurement is undertaken. Time‐dependent photoluminescence (PL) spectra measurements show that the TADF dendrons can act as an energy pool for emission from the phosphorescent core. The PL quantum yields (PLQYs) are found to be strongly dependent on the dielectric constant of the solvent, ranging from as high as 76% to as low as 0.3%. Neat films of the dendrimers are found to have relatively balanced hole and electron mobilities of order 10–6 cm2 V–1 s–1, with bilayer organic light‐emitting diodes (OLEDs) containing neat emissive layers having a maximum external quantum efficiency (EQE) of 4.7% for a film having a PLQY of 12%. Finally, the solution processed OLEDs fabricated using 0.4 mol% of the dendrimers blended with 9‐[3‐(9H‐carbazol‐9‐yl)phenyl]‐9H‐carbazole‐3‐carbonitrile result in green emission with maximum EQEs of 9.8% and 15.1% for the dendrimers with green and blue emissive TADF dendrons, respectively.

No abstract

Two light-emitting dendrimers composed of red phosphorescent fac-tris[2-(thiophen-2-yl)-4-(phenyl)quinoline]iridium(iii) cores and either blue (BR) or green (GR) thermally activated delayed fluorescence-based (TADF-based) dendrons have been prepared.

Percutaneous drug delivery using microneedles (MNs) has been extensively exploited to increase the transdermal permeability of therapeutic drugs. However, it is difficult to control the precise dosage with existing MNs and they need to be attached for a long time, so a more simple and scalable method is required for accurate transdermal drug delivery. In this study, we developed grooved MNs that can be embedded into the skin by mechanical fracture following simple shear actuation. Grooved MNs are prepared from hyaluronic acid (HA), which is a highly biocompatible and biodegradable biopolymer. By adjusting the aspect ratio (length:diameter) of the MN and the position of the groove, the MN tip inserted into the skin can be easily broken by shear force. In addition, it was demonstrated that it is possible to deliver the desired amount of triamcinolone acetonide (TCA) for alopecia areata by controlling the position of the groove structure and the concentration of TCA loaded in the MN. It was also confirmed that the tip of the TCA MN can be accurately delivered into the skin with a high probability (98% or more) by fabricating an easy-to-operate applicator to provide adequate shear force. The grooved MN platform has proven to be able to load the desired amount of a drug and deliver it at the correct dose.

No abstract